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Guggulsterone-mediated enhancement of radiosensitivity in 
human tumor cell lines
Rajani Choudhuri, William DeGraff, Janet Gamson, James B. Mitchell* and John A. Cook
Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Purpose: To observe the effect of guggulsterone (GS) on the radiation response in human cancer 
cell lines. Materials and methods: The radiation response of cancer cells treated with GS was 
observed by cell survival studies, cell growth assay, NF-κB activity assay, western blotting of 
some key growth promoting receptors, the DNA repair protein γH2AX, and flow cytometry 
for DNA analyses. Results: GS inhibited radiation induced NF-κB activation and enhanced 
radiosensitivity in the pancreatic cell line, PC-Sw. It reduced both cell cycle movement and cell 
growth. GS reduced ERα protein in MCF7 cells and IGF1-Rβ protein in colon cancer cells and 
pancreatic cancer cells and inhibited DNA double strand break (DSB) repair following radiation. 
Conclusion: GS induced radiation sensitization may be due to several different mechanisms 
including the inhibition of NF-κB activation and reductions in IGF1-Rβ. In addition, GS induced 
γH2AX formation, primarily in the S-phase, indicates that DNA DSB’s in the S-phase may 
be another reason for GS induced radiosensitivity. ERα down-regulation in response to GS 
suggests that it can be of potential use in the treatment of estrogen positive tumors that are 
resistant to tamoxifen.
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constitutive activation of NF-κB in tumor cells (Shishodia and 
Aggarwal, 2004). Activation of pro-survival pathways leading to 
inhibition of apoptosis can have effects on the radiosensitization 
of cells (Chautard et al., 2010). One such activator or pro-survival 
pathways is NF-κB which can be induced by ionizing radiation 
(IR; Li and Karin, 1998). Given the correlation between NF-κB 
activation with radiation and inhibition by GS we investigated 
the effect of GS on the radiosensitivity of human tumor cell 
lines. GS was found to down-regulate IR-induced activation of 
NF-κB and enhance the radiosensitivity of four human tumor 
cell lines. Further, GS was shown to inhibit cell growth and inhibit 
IR-induced DNA damage repair. These findings warrant further 
research toward evaluation of GS as IR modifier for potential 
clinical applications.
Materials and Methods
reagents
Guggulsterone was obtained from Steraloids, Inc. (Newport, RI, USA) 
and dissolved in DMSO at a concentration of 25 mM. Mouse mono-
clonal ER alpha and rabbit polyclonal ER beta antibodies were from 
LabVision Corp. (Fremont, CA, USA); rabbit polyclonal IGF-1Rβ, p21 
antibodies, and PARP-1 (F-2) were from Santa Cruz Biotechnology, 
Inc. (Santa Cruz, CA, USA); mouse monoclonal anti-phospho histone 
H2AX (Ser139), clone JBW301, and rabbit antiserum to histone H2A 
(acidic patch) were from Upstate Cell Signaling Solutions (Temecula, 
CA, USA). Mouse anti-actin antibody was purchased from Chemicon 
Intl. (Temecula, CA, USA). All the HRP linked secondary antibodies 
were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). 
Goat anti-mouse Alexa Fluor 488 secondary antibody was purchased 
from Invitrogen (Carlsbad, CA, USA).
introduction
A major goal in cancer therapy has been to identify drugs that 
are selectively cytotoxic to tumor cells in order to increase tumor 
control and lower the toxicity associated with normal tissue 
damage (Hait and Hambley, 2009; Hambley and Hait, 2009; Ma 
and Adjei, 2009). Alternatively another approach has been to 
identify agents, while not curative, may slow or even halt tumor 
growth over a long period of time, essentially turning cancer 
into a chronic and manageable disease. For this latter goal there 
has been renewed interest in natural products that may be less 
toxic to cells but still have important actions on blocking pro-
survival/growth signal transduction pathways. One such natural 
product is derived from an extract from guggul tree from India 
containing the compound, guggulsterone (GS; Shishodia et al., 
2008). GS is a derivative of the resin of guggul tree Commiphora 
mukul and has been widely reported as a hypolipidemic agent 
(Nityanand et al., 1989; Shishodia et al., 2008). Numerous animal 
and clinical studies have indicated its potential as a therapeutic 
agent for dyslipidemia (Dixit et al., 1980; Chander et al., 1996). 
Antagonism of the farnesoid X receptor (FXR) has been sug-
gested as the mechanism for the lipid lowering action of GS 
(Urizar et al., 2002). It has also been proposed that GS can bind 
to several steroid receptors at a higher affinity than to FXR (Burris 
et al., 2005). GS has also been found to activate estrogen receptor 
alpha (Erα), progesterone receptor (PR), and pregnane X recep-
tor (PXR; Brobst et al., 2004).
Interestingly, GS inhibits activation of NF-κB and decreases 
the expression of anti-apoptotic, angiogenic, and metastasis pro-
moting proteins (Shishodia and Aggarwal, 2004; Lv et al., 2008; 
Xiao and Singh, 2008). GS has been also reported to suppress the 
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Invitrogen (Carlsbad, CA, USA). Non-specific protein binding 
was blocked by incubating the membranes for 1 h in 3% blocking 
grade non-fat dry milk (Bio-Rad, Hercules, CA, USA) in TBST. 
The membranes were then left overnight at 4°C in the primary 
antibody at a dilution of 1:100 for ERα; 1:200 for ERβ, IGF-1Rβ, 
p21, and 1:5000 for anti-actin. The membranes were washed thrice 
in TBST and incubated for 1 h in horseradish peroxidase conju-
gated secondary antibody at a dilution of 1:2000 except for actin 
where the secondary antibody was used at a dilution of 1:10000. 
The proteins were then visualized by chemiluminescence (Perkin 
Elmer, Waltham, MA, USA) using Fluor Chem SP imager (Alpha 
Innotech, San Leandro, CA, USA).
For the determination of phosphohistone H2AX the cells were 
harvested and frozen at −70°C. The samples were thawed on ice and 
incubated on ice for 10 min in four volumes of lysis buffer (10 mM 
HEPES pH 7.9, 1.5 mM MgCl
2
, 10 mM KCl with 0.5 mM DTT, and 
1.5 mM PMSF). The samples were centrifuged at 14000 rpm for 
10 min in a refrigerated centrifuge. The supernatant was aspirated 
and the pellet was incubated on ice with 0.2 M H
2
SO
4
 for 4 h. The 
samples were centrifuged at 14000 rpm for 10 min at 4°C. The 
supernatant (acid soluble histones) was saved and nine volumes 
of ice cold acetone were added. The samples were kept overnight 
at −20°C. After centrifugation at 4°C the pellet was re-suspended 
in 4 M urea, protein estimated, and 20 μg of acid extracted pro-
tein run on 18% gels. Following transfer non-specific binding was 
blocked by incubating the membranes in 3% milk in TBST for 1 h 
and incubated overnight at 4°C in 1:10000 anti-phosphohistone 
H2AX antibody. The membranes were washed in TBST, incubated 
for 1 h in secondary antibody and visualized by chemiluminescence. 
The membranes were then stripped using Re-Blot Plus mild anti-
body stripping solution (Chemicon Int. Temecula, CA, USA) and 
re-probed with an H2A antibody for equal loading verification. 
Densitometric analysis of protein bands was accomplished with 
image analyzer software coupled with the Fluorchem FC800 system 
(Alpha Innotech, San Leandro, CA, USA). Density values for each 
protein were normalized to actin or other control protein values. 
All westerns were repeated 2–3 times and normalized against actin 
(in the case of Erα, ERβ, IGF-1Rβ, p21). The H2AX experiments 
were repeated twice and normalized against H2A.
Flow cytoMetry
Cell cycle analysis was conducted using 1 × 106 cells plated in 100 mm 
Petri dishes. The cells were either: (a) treated with GS (50 μM), (b) 
IR (7 Gy), or (c) treated with GS for 24 h and irradiated. After 24 h 
of incubation the cells were washed with PBS, trypsinized, fixed in 
cold 70% ethanol diluted in HBSS and stored at 4°C. Solutions were 
brought to room temperature and cells were centrifuged at 1000 rpm 
for 5 min and the supernatant discarded. The pellet was washed once 
in cold PBS and suspended in 1 ml of 20 μg/ml of propidium iodide 
solution containing 0.1% Triton X-100 and 500 ng of DNase free 
RNase. The cells were immediately analyzed for cell cycle changes. 
All flow experiments were repeated twice.
For γH2AX studies cells (106) were plated in 100 mm Petri 
dishes and following various treatments were fixed in 70% etha-
nol diluted in HBSS and stored at 4°C. The cells were then cen-
trifuged at 1000 rpm for 5 min in a refrigerated centrifuge and 
the  supernatant aspirated. The pellets were suspended in 1 ml of 
cell survival studies
HT29 (human colon carcinoma), MCF7 (human breast carci-
noma), MIA PaCa-2 (human pancreatic carcinoma), and Bx-PC3 
(human pancreatic carcinoma) cells were obtained from American 
Type Culture Collection (Rockville, MD, USA). PC-Sw (human 
pancreatic adenocarcinoma) cells were obtained from Dr. William 
Sindelar (Liebmann et al., 1994). All cell lines were grown in RPMI 
1640 supplemented with 10% fetal bovine serum, 100 units/ml 
penicillin and 50 μg/ml streptomycin. Stock cultures of cells were 
maintained in exponential growth in an incubator at 37°C in a 
humidified atmosphere of 95% air and 5% CO
2
.
For cell survival studies, cells were plated (5 × 105 cells/100 mm 
culture dishes) and incubated for 16 h at 37°C. GS was added to the 
exponentially growing cells 24 h prior to IR. A range of IR doses was 
delivered to cell samples using an Eldorado 8 cobalt-60 teletherapy 
unit (Theratronics International Ltd. Kanata, ON, Canada) at dose 
rates of 2.0–2.5 Gy/min. Vehicle control radiation survival curves 
were conducted in parallel. Twenty-four hours after IR and drug 
treatment, cells were trypsinized, counted, plated, and incubated for 
10–14 days. Colonies were fixed with methanol/acetic acid (3:1) and 
stained with crystal violet. Colonies with > 50 cells were scored and 
cell survival determined after correcting for the plating efficiency 
and for GS cytotoxicity alone. Survival curve data were fit using 
a linear-quadratic model according to Albright (1987). Survival 
curves for each cell were repeated 2–3 times. The dose modification 
factor (DMF) was determined by taking the ratio of IR doses at the 
10% survival level (control IR dose divided by the GS-treated IR 
dose). DMF values > 1 indicate enhancement of radiosensitivity.
cell growth assay
Cells (6 × 104) were plated in 60 mm Petri dishes and incubated over-
night. The next day 10, 25, and 50 μM Z-guggulsterone was added 
to the dishes (triplicate). After 120 h the cells were trypsinized with 
0.05% Trypsin–EDTA from Gibco (Carlsbad, CA, USA) and counted.
nF-κB activity assay
Nuclear extracts were prepared (Active Motif, Carlsbad, CA, USA) 
from HT29 and PC-Sw cells that were either (a) irradiated, or (b) 
treated with 50 or 100 μM GS for 24 h, or (c) pre-treated for 24 h 
with 50 or 100 μM GS and then irradiated. NF-κB p50 and p65 
transcription factor activity assays were carried out using the 
TransAM™ NF-κB family transcription factor assay kit (Active 
Motif, Carlsbad, CA, USA).
western Blotting
Cells (1 × 106) were plated in 100 mm Petri dishes. GS at various 
concentrations was added to the cells the following day. Twenty-four 
hours later some of the Petri dishes were irradiated with a single 
dose of 6 Gy. The next day all the samples were rinsed with cold PBS 
and the cells lysed in RIPA buffer (Santa Cruz Biotechnology, Inc. 
Santa Cruz, CA, USA). The samples were centrifuged at 14000 rpm 
in a refrigerated centrifuge and the supernatant collected. The sam-
ples were kept at 4°C if used on the same day or frozen at −70°C 
for storage. Protein concentration was determined with DC Protein 
Assay kit (Bio-Rad). Forty micrograms of protein was separated on 
Tris–Glycine gels (Invitrogen, Carlsbad, CA, USA) and transferred 
to nitrocellulose membrane using iBlot Dry Blotting System from 
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results
cell growth and cell cycle eFFects
Given the reported activation by GS of the various hormone 
receptors (Brobst et al., 2004) we initially set out to determine if 
GS would alter cell growth in the estrogen responsive breast cell 
line, MCF7. Figure 1A demonstrates that incubating MCF7 cells 
with 10 μM GS up to 120 h reduced cell growth by approximately 
60%. Figures 1B,C shows the effect of various concentrations of 
GS on two other tumor cell lines, HT29, and PC-Sw cells after 
120 h of growth. There was little effect of 10 μM GS on PC-Sw cell 
growth, however, this concentration did reduce growth in HT29 by 
35%. Greater growth inhibition was achieved using 25 and 50 μM 
GS, such that 50 μM GS incubation reduced growth by greater 
than 70% in all three cell lines (p < 0.05 for all three cell lines). 
Clonogenic survival studies indicated that the growth inhibition 
cold TST (TBS + 4% FBS + 0.1% Triton X-100) and left on ice for 
10 min. After centrifugation the supernatant was discarded and 
the cells were incubated on a shaker for 2 h at 4°C in 200 μl of 
1:500 anti-phosphohistone H2AX antibody diluted in TST. The 
cells were then rinsed with TST and incubated on a shaker at room 
temperature for 1 h in 200 μl of 1:200 secondary antibody (Alexa 
488 goat anti-mouse IgG). The cells were rinsed with cold TBS and 
5 μg/ml of propidium iodide in cold TBS was added to the cells. 
Both samples for DNA analysis and γH2AX studies were analyzed 
using a BD FACS Calibur (BD Biosciences, San Jose, CA, USA).
statistical Methods
Experiments were repeated 2–3 times and means and SD deter-
mined. Student’s t-test was used to determine the significance of 
p-values indicated.
FiguRe 1 | effect of gS on cell growth and cell cycle movement. Cell growth 
measurements for (A) MCF7 cells, (B) HT29 cells, and (C) PC-Sw cells 
incubated with 0, 10, 25, or 50 μM GS over a 5-day period. Cells were plated 
initially at 2 × 105 and counted after 5 days of growth. Flow cytometry study of 
PC-Sw cells treated either with 6 Gy of IR or treated with 50 μM GS for 24 h 
followed by 6 Gy IR. (D) untreated PC-Sw cells (solid line) vs 24 h GS-treated 
PC-Sw cells (dotted line). (e) 6 h post-IR (solid line) vs 6 h post-IR + 50 μM GS 
(dotted line) cells, (F) 12 h post-IR (solid line) vs 12 h post-IR + 50 μM GS (dotted 
line) cells, (g) 18 h post-IR (solid line) vs 18 h post-IR vs 18 h post-IR + 50 μM GS 
(dotted line) cells.
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p21 expression
Guggulsterone has been shown to induce the cyclin dependent 
kinase inhibitor, p21WAF/CIP1, leading to cell cycle blocks (Shishodia 
et al., 2007). The effects of IR and GS treatment on p21WAF/CIP1 induc-
tion were evaluated in two human tumor cell lines differing in their 
p53 status (MCF7, p53 normal; HT29 p53 mutated). In both cells 
lines p21WAF/CIP1 was up-regulated by either 50 μM (10.6 ± 0.2-fold 
for the HT29 and 3.45 ± 2.4-fold for MCF7 cells) or 100 μM GS 
(Figure 3). IR alone increased p21WAF/CIP1 in MCF7 cells, but not 
HT29 cells suggesting that GS must increase p21WAF/CIP1 via a p53 
and IR-independent mechanism.
gs-Mediated radiosensitivity
The ability to interfere with cell cycle movement after IR expo-
sure suggested that GS might alter the radiosensitivity of cells. 
Pilot studies initially carried out with PC-Sw cells indicated that 
50 μM GS incubation for times greater than 4 h increased cyto-
toxicity after a single 6 Gy IR dose (6 Gy alone = 0.278 (relative 
survival), 6 Gy + 4 h GS = 0.269, 6 Gy + 8 h GS = 0.152, 6 Gy + 18 h 
GS = 0.133, 6 Gy + 24 h GS = 0.186). Subsequently, for full dose 
survival curves, cells were pre-treated for 24 h with GS (50 or 
100 μM final  concentration) followed by IR. Studies with multiple 
found was not due to GS toxicity as 50 μM GS incubation showed 
minimal toxicity on the MCF7, HT29, or the PC-Sw cells (Table 1). 
Given the growth inhibitory effects of GS, studies were conducted 
to determine if the GS induced growth inhibition lead to altered 
cell cycle distribution. As seen in Figure 1D 50 μM GS incubation 
alone in PC-Sw cells did alter the cell cycle distribution after 24 h 
incubation (%G1 increased from 34 to 51, %S decreased from 
44 to 36, and %G2/M decreased from 22 to 12; Figure 1D). To 
determine if GS was inhibiting cell cycle movement, PC-Sw cells 
were irradiated with 6 Gy (with or without GS pre-treatment), 
after which cell cycle movement was followed for 18 h post-IR 
exposure. For IR treatment alone cells quickly moved out of G1 
(decreased from 20 to 8%) into S and blocked at the G2/M border 
(increased from 22 to 44%) 6 h post-treatment (Figure 1E). By 
12 h cells continued to leave S-phase and block in G2 (Figure 1F), 
and by 18 h had moved through the G2/M block as G1 increased 
from 16 to 58% (Figure 1G). In contrast, cells pre-treated for 24 h 
with 50 μM GS followed by IR showed no cell cycle movement 
over the entire time course examined [%G1(52% at 3 h – 54% at 
18 h), %S(40% at 3 h – 41% at 18 h), %G2/M(8% at 3 h – 5% at 
18 h)]. Thus, GS treatment completely blocked cell movement in 
all phases of the cell cycle following an exposure to IR.
eFFects on growth Factor receptors
Because of the profound effect of GS on the cell growth experi-
ments were conducted to determine what effect GS incubation was 
having on various growth factor receptors in these cells. Changes 
in three growth factor receptors, ERα, ERβ, and IGF-1Rβ were 
analyzed after 24 h GS incubation alone or in combination with IR 
in MCF7 cells. IR alone elevated ERα expression, while GS alone 
at both concentrations substantially down-regulated ERα protein 
levels (Figure 2A). Likewise, ERα expression was inhibited with the 
combination of IR and GS (Figure 2A). GS did not significantly 
affect either ERβ Figure 3A nor IGF-1Rβ levels in the MCF7 cells 
(Figure 2B) with any of the treatment combinations. Both the 
HT29 cells and PC-Sw cells tested negative for the Erα receptor 
(data not shown); however, Figure 2B shows that IGF-1Rβ was 
down-regulated by 24 h incubation with 50 or 100 μM GS (70–80% 
reduction). IR treatment alone showed little effect on IGR-1Rβ in 
these cells, while the combination of IR and GS was similar for GS 
alone treatment.
Table 1 | guggulsterone cytotoxicity alone and iR dose modification 
factors.
Cell Line gS Survival Alone (%) DMF*
 50 μM 100 μM gS50 μM gS100 μM
PC-Sw 76 ± 19 (SD) 26 1.52 ± 0.15† 1.92
MCF7 77 ± 28 43 ± 31 1.05 0.23 2.11 ± 0.39†
HT29 99 ± 0 88 ± 16 1.03 ± 0.04 1.32 ± 0.18
Bx-PC3 61 ± 14 26 1.34 ± 0.23 1.40 
MIA PaCa-2 99 ± 0 – 1.39 ± 0.02† –
*Control IR dose at 10% survival divided by the GS-treated IR dose at 10% 
survival ± SEM. SD, standard deviation. Bx-PC3 and PC-Sw were done only once 
at the 100-μM GS dose. †P-value < 0.05.
FiguRe 2 | The effect of gS and iR on eRα, eRβ, and igF-1Rβ levels. (A) 
MCF7 cells were treated with either 50 or 100 μM GS for 24 h and probed for 
ERα and ERβ changes. After treatment protein was isolated and processed for 
Western analysis to determine both ERα and ERβ levels. Blots were stripped 
and re-probed with actin antibodies. (B) MCF7, HT29, and PC-Sw cells were 
treated with 50 or 100 μM GS for 24 h and probed for changes in the levels of 
IGF-1Rβ. After treatment protein was isolated and processed for Western 
analysis to determine IGF-1Rβ levels. Blots were stripped and re-probed with 
actin antibodies. Numbers in parenthesis represent normalized protein levels 
using actin as the loading controls.
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was increased significantly with 100 μm GS incubation (Table 1). 
GS enhanced the radiosensitivity of the pancreatic cell lines at 
a concentration of 50 μM; whereas, the other cell lines did not 
show sensitization with this concentration. GS-mediated enhance-
ment of radiosensitivity was observed in all the cell lines that were 
pre-treated with 100 μM GS with DMFs ranging from 1.3 to 2.1 
(Table 1).
phosphorylation oF h2ax
To assess the effects of GS on IR-induced DNA damage and repair, 
phosphorylation of the H2AX protein (γH2AX) was evaluated. 
Cells were pre-treated without or with 50 or 100 μM GS, exposed 
to 6 Gy, rinsed, and incubated in fresh medium. Figure 5A shows 
γH2AX levels as a function of time after IR in MCF7, HT29, or 
PC-Sw cells. All three cell lines exhibited increased γH2AX levels 
1 h post-IR (5.7 ± 2.8, 4.8, and 5.4 ± 0.8, for MCF7, HT29, and 
PC-Sw cells, compared to control intensities, respectively). These 
levels were reduced at 24 h post-IR indicating repair. Pre-treatment 
using 50 μM GS followed by IR did not change the kinetics of IR 
repair in any of the cell lines tested. However, 100 μM GS pre-
treatment did inhibit DNA repair in the MCF7 and HT29 cells 
as the γH2AX remained elevated at 24 h. GS treatment alone also 
induced γH2AX formation in the MCF7 (2.4 ± 0.4) and HT29 
(5.1) cells as did 100 μM GS, while 50 μM GS treatment alone also 
increased γH2AX expression (2.8 ± 0.8) in the PC-Sw cells. Since 
FiguRe 3 | p21WAF/CiP1 induction post-iR and gS exposure on MCF7 or 
HT29 cells. Cells were treated with either 50 or 100 μM GS alone for 24 h or 
with 50 or 100 μM GS for 24 h followed by 6 Gy of IR. Protein was extracted 
after a 24-h post-IR period. Western analysis was done to determine p21WAF/CIP1 
levels. Blots were stripped and re-probed with actin antibodies for loading 
controls. Numbers in parenthesis represent the normalized p21 levels 
determined using actin as the loading control.
FiguRe 4 | Radiation cell survival curves for cells pre-incubated for 24 h with or without 50 or 100 μM gS and then exposed to varying doses of iR. (A) 
PC-Sw cells incubated with 50 μM GS for 24 h, (B) MCF7 cells incubated with 100 μM GS (C) HT29 cells incubated with 100 μM GS, (D) BX-PC3 cells incubated with 
100 μM GS. GS cytotoxicity data and DMFs are shown in Table 1.
cancer cell lines (MCF7, HT29, Bx-PC3, DU145) showed enhanced 
radiosensitization after GS incubation (Figure 4; Table 1). As indi-
cated, 50 μM GS incubation was not cytotoxic alone but toxicity 
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evaluated. NF-κB activation after 10 Gy IR was observed in both 
cell lines since an increase in the levels of the p50 (26% – HT29, 
66% PC-Sw) and p65 (73% – HT29, 24% – PC-Sw) subunits was 
observed as shown in Figure 6. Constitutive NF-κB activity was 
reduced by GS treatment alone at 50 μM (p65 ∼ 30% for PC-Sw, 
8% for HT29; p50 ∼ 19% PC-Sw, 14% for HT29) and 100 μM 
(p65 ∼ 33% for PC-Sw, 19% for HT29; p50 ∼ 30% for PC-Sw, 
20% for HT29), although in some cases not significantly. After IR 
treatment GS significantly lowered the radiation induced NF-κB 
activity for p65 (51–52% for PC-Sw and 94–96% for HT29) and 
p50 (90–95% for PC-Sw and 52–57% for HT29) in both cell lines.
discussion
Guggulsterone, a plant polyphenol, has several interesting bio-
logical properties that may have clinical applications. GS has been 
evaluated as an anti-hyperlipidemia agent with several clinical tri-
als yielding inconclusive results (Szapary et al., 2003; Nohr et al., 
2009). The anti-tumor activity of GS appears to be related to 
apoptotic mechanisms in a variety of tumor cell lines (Shishodia 
and Aggarwal, 2004; Samudio et al., 2005; Singh et al., 2005, 2007; 
GS treatment alone increased γH2AX levels, we examined whether 
the γH2AX levels were increased uniformly in all parts of the cell 
cycle of PC-Sw cells by using flow cytometry with simultaneous 
DNA and γH2AX labeling (Figures 5B,C). Compared to untreated 
controls, a 24-h 50 μM GS treatment predominantly increased the 
γH2AX levels in S-phase cells.
Additional studies were conducted to determine if the H2AXγ 
observed was accompanied by the formation of the cleaved PARP 
fragment. MCF7 cells showed a cleaved PARP fragment after 72 h 
incubation with 100 μM GS while the HT29 cells showed damage by 
48 h with 100 μM incubation (data not shown). HT29 cells showed 
a small amount of cleaved PARP with 50 μM GS only after 72 h GS 
incubation (data not shown). Neither the MCF7 nor the HT29 cells 
showed any cleaved PARP after 24 h GS incubation.
nF-κB activation
It has been suggested that inactivation of NF-κB can enhance IR 
sensitization in cell lines (Deorukhkar and Krishnan, 2010). Since 
GS has been shown to suppress TNF-mediated NF-κB activation 
(Shishodia and Aggarwal, 2004) we examined if GS could alter 
NF-κB activation after radiation exposure. HT29 and PC-Sw cells 
were pre-treated with GS (50 and 100 μM) for 24 h alone, exposed 
to 10 Gy alone or incubated with GS and irradiated with 10 Gy and 
analyzed for NF-κB activation 3 h post-IR using a nuclear trans-
activation assay. Two different NF-κB subunits (p50 and p65) were 
FiguRe 5 | effect of gS and iR exposure on γH2AX formation in various 
cell lines. (A) MCF7, HT29, and PC-Sw cells were treated with 6 Gy IR alone, 
50 or 100 μM GS for 24 h alone, or 50 or 100 μM GS for 24 h followed by 6 Gy 
IR exposure. Samples for γH2AX induction were taken at 1 and 24 h. Two 
parameter flow cytometry histograms of γ-H2AX versus DNA content in 
control (B) or GS treated (C) PC-Sw cells. Cells were treated with 50 μM GS 
for 24 h and were then fixed and analyzed using an anti-γH2AX antibody and 
co-stained with PI for total DNA content.
FiguRe 6 | NF-κB p50 and p65 activity in HT29 and PC-Sw cells 
measured after gS and iR exposure. Cells were pre-treated with GS (50  
and 100 μM) for 24 h alone, exposed to 10 Gy alone, or incubated with GS  
and irradiated with 10 Gy and analyzed for NF-κB activation 3 h post-IR  
using a nuclear transactivation assay for NF-κB p50 (A) or NF-κB p65 (B). 
*p values < 0.05 compared to control, †p values compared to IR.
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Shishodia et al., 2007; An et al., 2009) and also in differentiating 
3T3-L1 adipocytes (Yang et al., 2008), implicating consideration of 
GS in obesity. Our initial interest in GS came from studies show-
ing that GS inhibits the activation of NF-κB a nuclear transcrip-
tion factor that activates pro-survival pathways (Wang et al., 1996; 
Shishodia and Aggarwal, 2004). Since IR induces both NF-κB trans-
location and activation, we examined whether the inhibition of this 
pro-survival pathway by GS might lead to enhanced radiosensitiv-
ity via this mechanism. Support for this mechanism was found in 
the PC-Sw cells where 50 μM GS incubation inhibited IR-induced 
NF-κB activation (Figure 6) and increased the radiosensitization 
in these cells (Figure 4A). However, it is unlikely that this is the 
only mechanism, since 50 μM GS inhibited IR-induced NF-κB 
activation in the HT29 cells (Figure 6) but failed to enhance the 
radiosensitivity in these cells (Figure 4C). As previously reported, 
GS treatment not only inhibited IR-induced NF-κB activation, it 
also lowered constitutive NF-κB activation in control untreated 
cells (Figure 6; Shishodia and Aggarwal, 2004).
Because the GS inhibition of NF-κB activation did not com-
pletely correlate with radiation sensitivity we also examined sev-
eral other potential mechanisms of sensitization. First, given the 
propensity of GS to interact with several nuclear receptors such 
as PR, PXR, and ERα we examined if GS could interact with the 
IGF-1Rβ receptor, a receptor linked with radiation sensitization 
(Macaulay et al., 2001). Expression of IGF-1Rβ has been shown 
to confer radioresistance in cancer patients (Rocha et al., 1997). It 
has also been shown that inactivation of IGF-1Rβ radiosensitizes 
human lung cancer cells (Cosaceanu et al., 2005). We observed in 
PC-Sw and HT29 cells, that either 50 μM GS (in PC-Sw cells) or 
100 μM GS (in the HT29 cells) incubation did decrease the IGF-1Rβ 
levels (Figure 2B), and this decrease correlated with the induction 
of radiosensitization seen in these cells (Figures 4A,C). However, 
IGF-1Rβ in MCF7 cells showed minimal reduction after 100 μM 
GS incubation (Figure 2B) although this concentration of GS did 
increase sensitization to IR (Figure 4B). Hence, it is possible that 
the GS reduction of IGF-1Rβ may contribute to radiosensitiza-
tion in certain cell types but in others the effect of GS on different 
receptors may be more important (such as ERα in MCF7 cells). 
The mechanism of IGF-1Rβ receptor interaction in the repair of 
IR damage may be related to its effect on the repair related pro-
tein, ATM translocation (Macaulay et al., 2001; Peretz et al., 2001). 
Whether GS is altering this pathway remains to be determined.
Guggulsterone clearly interacts with steroidal receptors (Bovee 
et al., 2008) with the greatest activation being on the PR activity 
(Burris et al., 2005). It has been suggested that the direct interac-
tion of GS with the PXR receptor is partially responsible for the 
activation of this receptor (Brobst et al., 2004). Our data shows 
that GS treatment down-regulates the ERα receptor in MCF7 
cells. This is important because GS may have potential uses in 
estrogen positive tumors, which have developed resistance to the 
anti-estrogen, tamoxifen (Higgins and Stearns, 2009). Whether 
GS-mediated down-regulation of ERα plays a significant role in 
enhanced radiosensitivity will require further study. It is interest-
ing to note that tamoxifen and estradiol have been shown to alter 
radiosensitivity of MCF7 cells suggesting that perturbation of the 
ER pathway can influence radiation response (Wazer et al., 1989; 
Paulsen et al., 1996).
Along with the down-regulation of the estrogen receptor GS 
inhibited cell growth in a variety of human tumor cell lines. Other 
groups have reported inhibition of cell growth either by MTT 
assay or 3H-thymidine uptake (Singh et al., 2005, 2007). Growth 
inhibition was reported to occur because of a G1/S or S-phase 
block. (Singh et al., 2007) However, Figures 1E–G shows that when 
PC-Sw cells are irradiated and followed for cell cycle changes that 
all parts of the cell cycle appear to be affected by GS as almost no 
movement is observed after GS + IR treatments. Thus, it appears 
that GS completely abrogates or at least greatly slows down cell 
cycle movement in each part of the cell cycle, including G1, S, and 
G2/M. One molecular target responsible for cell cycle blockage 
with GS incubation was the induction of the CDKI p21WAF1/CIP1 
(Figure 3). Importantly, p21WAF1/CIP1 induction also occurred in p53 
mutated cells (HT29), which IR did not up-regulate (Figure 3), 
and hence, suggesting that GS up-regulates p21WAF1/CIP1 by a p53 
independent mechanism. Our cell cycle results do not entirely 
agree with earlier conclusions (Shishodia et al., 2007) that the 
block was in the S-phase part of the cell cycle in that GS incubation 
arrested cells in all parts of the cell cycle as clearly no movement 
was seen from any of the cell cycle compartments following a 
6-Gy dose. Shishodia et al. (2007) did find that cdc2 (CDK1) and 
cyclin D1 were down-regulated, and since these two components 
of the cell cycle would be expected to impact both G1 and G2/M 
progression it would seem likely that movement throughout the 
cell cycle would be impacted.
Guggulsterone was a potent radiosensitizer at 100 μM in all 
tumor cell lines studied (Figure 4; Table 1) while in several pancreas 
cell lines GS significantly increased radiosensitization using 50 μM 
GS (Table 1). Interestingly, this effect was correlated with the induc-
tion of γH2AX phosphorylation as 50 μM GS incubation increased 
γH2AX in the PC-Sw cells but not in the other cell lines (Figure 5). 
In addition, the other cell lines did show γH2AX phosphoryla-
tion when incubated with 100 μM GS (Figure 5). Thus it appears 
that GS can induce double strand breaks (DSB’s) in cells and this 
process could also be responsible for the increased radiosensitiza-
tion observed. One area, which has received increased attention, 
is the formation of γH2AX foci when cells are exposed to treat-
ments causing replication stress (Peretz et al., 2001; Chanoux et al., 
2009). These conditions (usually with drugs) act by inhibiting the 
rapid repair of DSB’s, which takes place during replication of the 
DNA during S-phase to relieve topological tension (Nitiss, 2009). 
Importantly, flow cytometry for γH2AX showed that GS-treated 
cells had γH2AX induced primarily in S-phase cells suggesting 
that GS was indeed acting to create sites of DSB’s (Figures 5B,C). 
Thus, one mechanism of radiosensitization may be the production 
of DSB’s in mid-to-late S-phase cells as this part of the cell cycle 
is considered to be the most resistant to IR exposure (Hall and 
Gaiaccia, 2006).
Another possible advantage of using GS as a clinical radiosen-
sitizer has been reported detailing the selectivity of GS for tumor 
vs normal cells. Earlier studies have showed that a normal prostate 
epithelial cell line is resistant to growth inhibition and apoptosis 
caused by GS when compared to prostate tumor cells (Singh et al., 
2005). We examined cleaved PARP after 100 μM GS incubation 
in both MCF7 and HT29 cells and found that cleaved PARP was 
observed only after 48 h in HT29 cells and 72 h GS incubation 
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